Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Wenzel

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Experimental Dermatology|May 12, 2005
The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activityJoerg Wenzel, Stephanie Henze, Sabine Brähler, et al.
Dermatology (Basel, Switzerland)|September 8, 2007
Generalized lichen nitidus with involvement of the palms following interferon alpha treatmentMarina Scheler, Julia Proelss, Wolfgang Bräuninger, et al.
Journal of the American Academy of Dermatology|February 24, 2007
Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosisJulia Proelss, Joerg Wenzel, Yon Ko, et al.
Acta Dermato-Venereologica|March 7, 2007
IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicusJoerg Wenzel, Andreas Wiechert, Christian Merkel, et al.
Frontiers in Immunology|June 16, 2023
Aberrant inflammasome activation as a driving force of human autoimmune skin diseaseTanja Fetter, Dennis Marinus de Graaf, Isabelle Claus, et al.
Journal of Cutaneous Pathology|March 17, 2005
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimodJoerg Wenzel, Manfred Uerlich, Otto Haller, et al.
Journal of Cutaneous Pathology|October 10, 2006
Type I interferon-associated cytotoxic inflammation in lichen planusJoerg Wenzel, Marina Scheler, Julia Proelss, et al.
Experimental Dermatology|November 29, 2016
JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosusAnna Sophie Klaeschen, Dominik Wolf, Peter Brossart, et al.
Dermatology (Basel, Switzerland)|October 26, 2002
Topical treatment of pyoderma gangraenosumJoerg Wenzel, Rainer Gerdsen, Wolfgang Phillipp-Dormston, et al.
Journal of the American Academy of Dermatology|March 21, 2007
CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundusJoerg Wenzel, Julia Proelss, Andreas Wiechert, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Experimental Dermatology|May 12, 2005
The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activityJoerg Wenzel, Stephanie Henze, Sabine Brähler, et al.
Dermatology (Basel, Switzerland)|September 8, 2007
Generalized lichen nitidus with involvement of the palms following interferon alpha treatmentMarina Scheler, Julia Proelss, Wolfgang Bräuninger, et al.
Journal of the American Academy of Dermatology|February 24, 2007
Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosisJulia Proelss, Joerg Wenzel, Yon Ko, et al.
Acta Dermato-Venereologica|March 7, 2007
IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicusJoerg Wenzel, Andreas Wiechert, Christian Merkel, et al.
Frontiers in Immunology|June 16, 2023
Aberrant inflammasome activation as a driving force of human autoimmune skin diseaseTanja Fetter, Dennis Marinus de Graaf, Isabelle Claus, et al.
Journal of Cutaneous Pathology|March 17, 2005
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimodJoerg Wenzel, Manfred Uerlich, Otto Haller, et al.
Journal of Cutaneous Pathology|October 10, 2006
Type I interferon-associated cytotoxic inflammation in lichen planusJoerg Wenzel, Marina Scheler, Julia Proelss, et al.
Experimental Dermatology|November 29, 2016
JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosusAnna Sophie Klaeschen, Dominik Wolf, Peter Brossart, et al.
Dermatology (Basel, Switzerland)|October 26, 2002
Topical treatment of pyoderma gangraenosumJoerg Wenzel, Rainer Gerdsen, Wolfgang Phillipp-Dormston, et al.
Journal of the American Academy of Dermatology|March 21, 2007
CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundusJoerg Wenzel, Julia Proelss, Andreas Wiechert, et al.
Pageof 9